Should the human microbiome be considered when developing vaccines?
PLoS Pathog
.
2010 Nov 18;6(11):e1001190.
doi: 10.1371/journal.ppat.1001190.
Authors
Rosana B R Ferreira
1
,
L Caetano M Antunes
,
B Brett Finlay
Affiliation
1
Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
PMID:
21124987
PMCID:
PMC2987818
DOI:
10.1371/journal.ppat.1001190
No abstract available
MeSH terms
Bacterial Infections / genetics*
Bacterial Infections / immunology
Bacterial Infections / prevention & control*
Drug Design*
Humans
Metagenome*
Vaccines / genetics*
Vaccines / immunology
Vaccines / therapeutic use*
Substances
Vaccines